Found: 5
Select item for more details and to access through your institution.
Prediction of a potentially effective dose in humans for BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modelling.
- Published in:
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 2, p. 219, doi. 10.1111/j.1365-2125.2011.04064.x
- By:
- Publication type:
- Article
Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition<sup>*</sup>.
- Published in:
- American Journal of Hypertension, 2001, v. 14, p. 55S, doi. 10.1016/S0895-7061(01)02070-2
- By:
- Publication type:
- Article
Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the α-glucosidase inhibitor acarbose.
- Published in:
- FASEB Journal, 2005, v. 19, n. 6, p. 591, doi. 10.1096/fj.04-2459fje
- By:
- Publication type:
- Article
Cholesteryl ester transfer protein and its inhibition.
- Published in:
- Cellular & Molecular Life Sciences, 2010, v. 67, n. 18, p. 3139, doi. 10.1007/s00018-010-0418-3
- By:
- Publication type:
- Article
Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarboxylate.
- Published in:
- Protein Science: A Publication of the Protein Society, 1999, v. 8, n. 10, p. 1930
- By:
- Publication type:
- Article